These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12679471)

  • 1. Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition.
    Welt CK; Pagan YL; Smith PC; Rado KB; Hall JE
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1766-71. PubMed ID: 12679471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
    Hall JE; Schoenfeld DA; Martin KA; Crowley WF
    J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
    Reame NE; Wyman TL; Phillips DJ; de Kretser DM; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3302-7. PubMed ID: 9745445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
    Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.
    le Nestour E; Marraoui J; Lahlou N; Roger M; de Ziegler D; Bouchard P
    J Clin Endocrinol Metab; 1993 Aug; 77(2):439-42. PubMed ID: 8345049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicle-stimulating hormone-inhibin B interactions during the follicular phase of the primate menstrual cycle revealed by gonadotropin-releasing hormone antagonist and antiestrogen treatment.
    Fraser HM; Groome NP; McNeilly AS
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1365-9. PubMed ID: 10199780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female reproductive aging is marked by decreased secretion of dimeric inhibin.
    Welt CK; McNicholl DJ; Taylor AE; Hall JE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):105-11. PubMed ID: 9920069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone.
    McCartney CR; Gingrich MB; Hu Y; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2002 May; 87(5):2194-200. PubMed ID: 11994363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control of FSH secretion.
    McNeilly AS
    Acta Endocrinol Suppl (Copenh); 1988; 288():31-40. PubMed ID: 3138865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of early ovarian aging in fragile X premutation carriers.
    Welt CK; Smith PC; Taylor AE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4569-74. PubMed ID: 15356064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.